MENU

CLLS Cellectis SA Forecast, Technical & Fundamental Analysis

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications... Show more

Industry: #Biotechnology
CLLS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
CLLS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CLLS is expected to report earnings to fall 14.41% to -18 cents per share on November 09

Cellectis SA CLLS Stock Earnings Reports
Q3'26
Est.
$-0.19
Q2'26
Beat
by $0.04
Q1'26
Beat
by $0.08
Q4'25
Beat
by $0.03
Q3'25
Beat
by $0.24
The last earnings report on August 06 showed earnings per share of -21 cents, beating the estimate of -25 cents. With 28.73K shares outstanding, the current market capitalization sits at 104.75M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NUGY11.340.04
+0.32%
GraniteShares YieldBOOST Gold Miners ETF (NUGY)
BCGS25.80N/A
N/A
Bancreek Global Select ETF (BCGS)
UMAY38.88-0.20
-0.50%
Innovator U.S. Equity Ultra Buffer ETF - May (UMAY)
MAYW35.54-0.19
-0.53%
AllianzIM U.S. Equity Buffer20 May ETF (MAYW)
NULV53.88-0.39
-0.72%
Nuveen ESG Large-Cap Value ETF (NULV)

CLLS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CLLS has been loosely correlated with SLN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CLLS jumps, then SLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLLS
1D Price
Change %
CLLS100%
-5.88%
SLN - CLLS
43%
Loosely correlated
-7.17%
MDGL - CLLS
40%
Loosely correlated
-2.19%
PMVP - CLLS
38%
Loosely correlated
-6.20%
AXON - CLLS
36%
Loosely correlated
-6.45%
TGTX - CLLS
36%
Loosely correlated
-3.62%
More
A.I. Advisor
published General Information

General Information

a genome engineering company of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers

Industry Biotechnology

Industry
Biotechnology
Address
8, rue de la Croix Jarry
Phone
+33 181691600
Employees
186
Web
https://www.cellectis.com